IIA
HURA

IPG Investment Advisors’s TuHURA Biosciences HURA Stock Holding History

IPG Investment Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15
Closed -$36.4K – 196
2020
Q3 		$36.4K Buy
+15
New +$30.2K 0.01% 151

Other funds holding HURA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APA
Allegiant Private Advisors Sarasota, Florida $618M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IPG Investment Advisors's HURA Position: Q4 2020 in Review

IPG Investment Advisors sold out of TuHURA Biosciences (HURA) in Q4 2020, closing a stake of 15 shares — an estimated $36.4K sold.

IPG Investment Advisors first reported a position in HURA in Q3 2020 and held it in 1 quarter. The position peaked at $36.4K in Q3 2020. 15 funds tracked by Wall St. Rank hold HURA as of Q4 2020.

  • IPG Investment Advisors reported no remaining TuHURA Biosciences position as of Q4 2020 after selling out during the quarter.
  • IPG Investment Advisors sold 15 TuHURA Biosciences shares in Q4 2020, an estimated $36.4K.
  • IPG Investment Advisors first reported a position in TuHURA Biosciences in Q3 2020 and held it in 1 quarter.
  • IPG Investment Advisors's TuHURA Biosciences position peaked at $36.4K in Q3 2020.
  • 15 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2020.

Based on IPG Investment Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.